Ondansetron Solution
Product Images NDC 65862-208

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 65862-208). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (4 mg/5 mL (50 mL Bottle))

Package Label-principal Display Panel (4 mg/5 mL (50 mL Bottle))
This is a description of a medication called Ondansetron Oral Solution, which is distributed by Aurobindo Pharma USA, Inc. The solution comes in a 5mL bottle and contains ondansetron hydrochloride, equivalent to 4mg of ondansetron base. The usual dosage is available in the package insert. The medication is manufactured in India and can be stored between 15°C to 30°C. The solution needs to be protected from light and the bottle needs to be stored upright in the carton. The product is labeled as Rx only. There is also a coding area mentioned in the text.*
FDA Label Image

Package Label-principal Display Panel (4 mg/5 mL Container Carton)

Package Label-principal Display Panel (4 mg/5 mL Container Carton)
Ondansetron Oral Solution, USP is a medication with the National Drug Code 65862-208-04. It is used to prevent nausea and vomiting associated with certain medical treatments. It comes in a 2-ounce (60-milliliter) bottle and should be stored at room temperature. The recommended dosage should be determined by a healthcare professional. It is distributed by Aurobindo Pharma USA, located in Princeton.*
FDA Label Image

Chemical Structure (Ondansetron Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.